Browse Medical Research Based on Condition

    FOR ACNE
    FOR ADD / ADHD
    FOR ADDICTION
    FOR ALS
    FOR ALZHEIMERS
    FOR ANOREXIA
    FOR ANXIETY
    FOR ATHEROSCLEROSIS
    FOR ARTHRITIS
    FOR ASTHMA
    FOR AUTISM
    FOR BIPOLAR AFFECTIVE DISORDER
    FOR CANCER – GENERAL
    FOR CANCER – LUNG

    FOR CANCER – PROSTATE/COLON
    FOR CANCER – BREAST
    FOR CANCER – BRAIN
    FOR CANCER – LEUKEMIA
    FOR CANCER – SKIN
    FOR CANCER – ENDOCRINE
    FOR CANCER – BLADDER
    FOR CANCER – PAIN RELIEF
    FOR CROHNS & COLITIS
    FOR DEPRESSION
    FOR ENDOCRINE DISORDERS
    FOR FIBROMYALGIA
    FOR GLAUCOMA
    FOR HEART DISEASE

    FOR HUNTINGTONS DISEASE
    FOR INFLAMMATION
    FOR IRRITABLE BOWEL SYNDROME
    FOR KIDNEY DISEASE
    FOR LIVER DISEASE
    FOR METABOLIC SYNDROME
    FOR MIGRAINES
    FOR MOOD DISORDERS
    FOR MOTION SICKNESS
    FOR MULTIPLE SCLEROSIS
    FOR NAUSEA
    FOR NEURODEGENERATION
    FOR NEUROPATHIC PAIN
    FOR OBESITY

    FOR OCD
    FOR PARKINSONS DISEASE
    FOR PRION
    FOR PTSD
    FOR RHEUMATISM
    FOR SCHIZOPHRENIA
    FOR SICKLE CELL ANEMIA
    FOR SKIN CONDITIONS
    FOR SLEEP DISORDERS
    FOR SPINAL CORD INJURY
    FOR STRESS
    FOR STROKE/TBI

    FOR ACNE

     FOR ACNECannabidiol as a Treatment for Acne?
     FOR ACNECannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
     FOR ACNEThe endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities
     FOR ACNEEndocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling
     FOR ACNEEndocannabinoid signaling and epidermal differentiation

    FOR ADD / ADHD

     FOR ADD / ADHDSearching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders
     FOR ADD / ADHDCannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats
     FOR ADD / ADHDSubtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use
     FOR ADD / ADHDChildhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students
     FOR ADD / ADHDOral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report
     FOR ADD / ADHDFitness to drive in spite (because) of THC

    FOR ADDICTION

     FOR ADDICTIONCannabidiol reduces cigarette consumption in tobacco smokers
     FOR ADDICTIONCannabidiol inhibits the reward-facilitating effect of morphine
     FOR ADDICTIONCannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances
     FOR ADDICTIONDifferential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats
     FOR ADDICTIONImpact of Cannabis Use during Stabilization on Methadone Maintenance Treatment
     FOR ADDICTIONMedical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010
     FOR ADDICTIONDysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents
     FOR ADDICTIONComparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity
     FOR ADDICTIONTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
     FOR ADDICTIONCannabidiol for the treatment of cannabis withdrawal syndrome

    FOR ALS

     FOR ALSCannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials
     FOR ALSALS: delayed disease progression in mice by treatment with a cannabinoid
     FOR ALSThe (Endo)Cannabinoid System in Multiple Sclerosis and ALS
     FOR ALSSurvey of cannabis use in patients with ALS

    FOR ALZHEIMERS

     FOR ALZHEIMERSThe therapeutic potential of the endocannabinoid system for Alzheimer’s disease
     FOR ALZHEIMERSEndocannabinoid signalling in Alzheimer’s disease
     FOR ALZHEIMERSA molecular link between the active component of marijuana and Alzheimer’s disease pathology
     FOR ALZHEIMERSNeuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
     FOR ALZHEIMERSThe Potential Therapeutic Effects of THC on Alzheimer’s Disease
     FOR ALZHEIMERSThe Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
     FOR ALZHEIMERSCannabinoids for the treatment of dementia
     FOR ALZHEIMERSCannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
     FOR ALZHEIMERSCannabidiol: A promising drug for neurodegenerative disorders?
     FOR ALZHEIMERSCannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
     FOR ALZHEIMERSThe role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses
     FOR ALZHEIMERSThe role of phytochemicals in the treatment and prevention of dementia
     FOR ALZHEIMERSCannabinoids for the treatment of dementia
     FOR ALZHEIMERSCannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
     FOR ALZHEIMERSCannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
     FOR ALZHEIMERSCan Marijuana Prevent Alzheimer’s?

    FOR ANOREXIA

     FOR
    ANOREXIA    		Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa
     FOR
    ANOREXIA    		The role of the endocannabinoid system in eating disorders: Neurochemical and behavioural preclinical evidence
     FOR
    ANOREXIA    		Cancer cachexia and cannabinoids
     FOR
    ANOREXIA    		Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa

    FOR ANXIETY

     FOR ANXIETYCannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
     FOR ANXIETYAntidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa
     FOR ANXIETYCannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
     FOR ANXIETYNeural basis of anxiolytic effects of cannabidiol (Hemp Extract) in generalized social anxiety disorder
     FOR ANXIETYCentral anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
     FOR ANXIETYEffects of cannabidiol (Hemp Extract) on regional cerebral blood flow
     FOR ANXIETYThe anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
     FOR ANXIETYThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
     FOR ANXIETYPlant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence

    FOR ATHEROSCLEROSIS

     FOR
    ATHEROSCLEROSIS    		The role of the endocannabinoid system in atherosclerosis
     FOR
    ATHEROSCLEROSIS    		Cannabinoid receptors in atherosclerosis
     FOR
    ATHEROSCLEROSIS    		The potential use of cannabidiol in the therapy of metabolic syndrome
     FOR
    ATHEROSCLEROSIS    		Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

    FOR ARTHRITIS

     FOR
    ARTHRITIS    		Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
     FOR
    ARTHRITIS    		The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
     FOR
    ARTHRITIS    		The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
     FOR
    ARTHRITIS    		Arthritis and cannabinoids

    FOR ASTHMA

     FOR ASTHMAThe role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke
     FOR ASTHMAAllergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma
     FOR ASTHMAActivation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs
     FOR ASTHMAEndogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways
     FOR ASTHMABronchodilator effect of delta1-tetrahydrocannabinol

    FOR AUTISM

     FOR
    AUTISM    		Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain
     FOR
    AUTISM    		Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
     FOR
    AUTISM    		A novel approach to the symptomatic treatment of autism
     FOR
    AUTISM    		Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders
     FOR AUTISMTargeting the endocannabinoid system in the treatment of fragile X syndrome

    FOR BIPOLAR AFFECTIVE DISORDER

     FOR
    BIPOLAR AFFECTIVE DISORDER    		Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential
     FOR
    BIPOLAR AFFECTIVE DISORDER    		Cannabidiol was ineffective for manic episode of bipolar affective disorder
     FOR
    BIPOLAR AFFECTIVE DISORDER    		Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania
     FOR
    BIPOLAR AFFECTIVE DISORDER    		Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis
     FOR
    BIPOLAR AFFECTIVE DISORDER    		The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research

    FOR CANCER - GENERAL

     FOR
    CANCER – GENERAL    		Cannabidiol as potential anticancer drug
     FOR
    CANCER – GENERAL    		Cannabidiol inhibits angiogenesis by multiple mechanisms
     FOR
    CANCER – GENERAL    		The inhibitory effects of cannabidiol on systemic malignant tumors
     FOR
    CANCER – GENERAL    		Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
     FOR
    CANCER – GENERAL    		Marijuana fights cancer and helps manage side effects

    FOR CANCER - LUNG

     FOR
    CANCER – LUNG    		Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1C
     FOR
    CANCER – LUNG    		COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells
     FOR
    CANCER – LUNG    		Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells
     FOR
    CANCER – LUNG    		Media ignored expert’s shocking findings that marijuana helps prevent lung cancer

    FOR CANCER - PROSTATE/COLON

     FOR CANCER – PROSTATE/COLONTowards the use of non-psychoactive cannabinoids for prostate cancer
     FOR CANCER – PROSTATE/COLONIn Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines
     FOR CANCER – PROSTATE/COLONInduction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
     FOR CANCER – PROSTATE/COLONChemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
     FOR CANCER – PROSTATE/COLONInhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol

    FOR CANCER - BREAST

     FOR CANCER – BREASTAntitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
     FOR CANCER – BREASTCannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
     FOR CANCER – BREASTPathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
     FOR CANCER – BREASTCannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
     FOR CANCER – BREASTCannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration

    FOR CANCER - BRAIN

     FOR CANCER – BRAINCannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
     FOR CANCER – BRAINAntitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed)
     FOR CANCER – BRAINSystematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas
     FOR CANCER – BRAINCannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
     FOR CANCER – BRAINId-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target
     FOR CANCER – BRAINTriggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
     FOR CANCER – BRAINCannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect
     FOR CANCER – BRAINLocal delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme

    FOR CANCER - LEUKEMIA

     FOR CANCER – LEUKEMIACannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression
     FOR CANCER – LEUKEMIACannabidiol-Induced Apoptosis in Human Leukemia Cells
     FOR CANCER – LEUKEMIACannabidiol Reduces Leukemic Cell Size – But Is It Important?
     FOR CANCER – LEUKEMIATargeting cannabinoid receptors to treat leukemia

    FOR CANCER - SKIN

     FOR CANCER – SKINAnticancer activity of anandamide in human cutaneous melanoma cells
     FOR CANCER – SKINCannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium (PubMed)
     FOR CANCER – SKINCannabinoid receptors as novel targets for the treatment of melanoma
     FOR CANCER – SKINThe Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development

    FOR CANCER - ENDOCRINE

     FOR CANCER – ENDOCRINEEndocannabinoids in endocrine and related tumours
     FOR CANCER – ENDOCRINEA comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells
     FOR CANCER – ENDOCRINECannabinoids in pancreatic cancer: Correlation with survival and pain
     FOR CANCER – ENDOCRINECannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma

    FOR CANCER - BLADDER

     FOR CANCER – BLADDERTRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer
     FOR CANCER – BLADDERAssociation Between Cannabis Use and the Risk of Bladder Cancer
     FOR CANCER – BLADDERInhibitory Effect of Standardized Cannabis sativaExtract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility
     FOR CANCER – BLADDERBladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism

    FOR CANCER - PAIN RELIEF

     FOR CANCER – PAIN RELIEFMulticenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:hemp extract and THC extract in patients with intractable cancer-related pain
     FOR CANCER – PAIN RELIEFNabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
     FOR CANCER – PAIN RELIEFMarijuana extract helps prevent chemo pain
     FOR CANCER – PAIN RELIEFAn Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/Hemp Extract Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics

    FOR CROHNS & COLITIS

     FOR CROHNS & COLITISCannabidiol in inflammatory bowel diseases: a brief overview
     FOR CROHNS & COLITISCannabis finds its way into treatment of Crohn’s disease
     FOR CROHNS & COLITISCannabidiol reduces intestinal inflammation through the control of neuroimmune axis
     FOR CROHNS & COLITISCannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
     FOR CROHNS & COLITISThe effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
     FOR CROHNS & COLITISTopical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
     FOR CROHNS & COLITISCannabinoids and the gut: New developments and emerging concepts
     FOR CROHNS & COLITISEndocannabinoids and the gastrointestinal tract
     FOR CROHNS & COLITISCannabinoids and gastrointestinal motility: Animal and human studies
     FOR CROHNS & COLITISHergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis

    FOR DEPRESSION

     FOR DEPRESSIONEndocannabinoid system dysfunction in mood and related disorders
     FOR DEPRESSIONAntidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa
     FOR DEPRESSIONThe endocannabinoid system and the treatment of mood and anxiety disorders
     FOR DEPRESSIONEndocannabinoid signaling in the etiology and treatment of major depressive illness
     FOR DEPRESSIONAntidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
     FOR DEPRESSIONPutative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
     FOR DEPRESSIONAntidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa
     FOR DEPRESSIONCirculating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
     FOR DEPRESSIONSerum contents of endocannabinoids are correlated with blood pressure in depressed women
     FOR DEPRESSIONThe therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
     FOR DEPRESSIONAntidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures

    FOR ENDOCRINE DISORDERS

     FOR ENDOCRINE DISORDERSEndocannabinoid system participates in neuroendocrine control of homeostasis
     FOR ENDOCRINE DISORDERSThe emerging role of the endocannabinoid system in endocrine regulation and energy balance
     FOR ENDOCRINE DISORDERSEndocannabinoids in endocrine and related tumours
     FOR ENDOCRINE DISORDERSRole of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
     FOR ENDOCRINE DISORDERSThe role of the endocannabinoid system in the neuroendocrine regulation of energy balance
     FOR ENDOCRINE DISORDERSHemp Extract for children with Dravet’s and intractable seizures
     FOR ENDOCRINE DISORDERSReport of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
     FOR ENDOCRINE DISORDERSMedicinal marijuana stops seizures, brings hope to a little girl
     FOR ENDOCRINE DISORDERSCannabinoids for epilepsy
     FOR ENDOCRINE DISORDERSCannabis, cannabidiol, and epilepsy – From receptors to clinical response
     FOR ENDOCRINE DISORDERSThe non-psychotropic plant cannabinoids, cannabidivarin and cannabidiol, activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability
     FOR ENDOCRINE DISORDERSChronic administration of cannabidiol to healthy volunteers and epileptic patients
     FOR ENDOCRINE DISORDERSEndocannabinoid system protects against cryptogenic seizures
     FOR ENDOCRINE DISORDERSSeizing an opportunity for the endocannabinoid system
     FOR ENDOCRINE DISORDERSCannabidiol: promise and pitfalls
     FOR ENDOCRINE DISORDERSCannabidivarin suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression
     FOR ENDOCRINE DISORDERSCannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
     FOR ENDOCRINE DISORDERSCannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
     FOR ENDOCRINE DISORDERSHypnotic and antiepileptic effects of cannabidiol
     FOR ENDOCRINE DISORDERSThe cannabinoids as potential antiepileptics
     FOR ENDOCRINE DISORDERSCannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats

    FOR FIBROMYALGIA

     FOR FIBROMYALGIAClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
     FOR FIBROMYALGIACannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life
     FOR FIBROMYALGIAAssociation of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia
     FOR FIBROMYALGIACannabinoids for fibromyalgia
     FOR FIBROMYALGIAMedical Cannabis for the Treatment of Fibromyalgia

    FOR GLAUCOMA

     FOR GLAUCOMANeuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite
     FOR GLAUCOMACannabinoids and glaucoma
     FOR GLAUCOMAThe treatment of glaucoma using a non-psychoactive preparation of Cannabis sativa
     FOR GLAUCOMACannabinoids for treatment of glaucoma

    FOR HEART DISEASE

     FOR HEART DISEASEIs the cardiovascular system a therapeutic target for cannabidiol?
     FOR HEART DISEASEAcute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
     FOR HEART DISEASECannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
     FOR HEART DISEASEThe Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias: The Role of Adenosine A1 Receptors
     FOR HEART DISEASECannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
     FOR HEART DISEASEEndocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
     FOR HEART DISEASEOleamide: A fatty acid amide signaling molecule in the cardiovascular system?

    FOR HUNTINGTONS DISEASE

     FOR HUNTINGTONS DISEASENeuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease
     FOR HUNTINGTONS DISEASECannabinoids: Novel medicines for the treatment of Huntington’s disease
     FOR HUNTINGTONS DISEASESativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors
     FOR HUNTINGTONS DISEASEControlled clinical trial of cannabidiol in Huntington’s disease
     FOR HUNTINGTONS DISEASEProspects for cannabinoid therapies in basal ganglia disorders
     FOR HUNTINGTONS DISEASENeuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

    FOR INFLAMMATION

     FOR INFLAMMATIONCannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
     FOR INFLAMMATIONThe endocannabinoid system: an emerging key player in inflammation
     FOR INFLAMMATIONAnti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
     FOR INFLAMMATIONCannabinoids, endocannabinoids, and related analogs in inflammation
     FOR INFLAMMATIONCannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor
     FOR INFLAMMATIONCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
     FOR INFLAMMATIONCannabidiol reduces intestinal inflammation through the control of neuroimmune axis
     FOR INFLAMMATIONDiabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
     FOR INFLAMMATIONCannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
     FOR INFLAMMATIONCannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
     FOR INFLAMMATIONVanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
     FOR INFLAMMATIONCannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

    FOR IRRITABLE BOWEL SYNDROME

     FOR IRRITABLE BOWEL SYNDROMECannabidiol in inflammatory bowel diseases: A brief overview
     FOR IRRITABLE BOWEL SYNDROMECannabidiol reduces intestinal inflammation through the control of neuroimmune axis
     FOR IRRITABLE BOWEL SYNDROMEClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
     FOR IRRITABLE BOWEL SYNDROMECannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
     FOR IRRITABLE BOWEL SYNDROMETherapeutic potential of cannabinoid-based drugs
     FOR IRRITABLE BOWEL SYNDROMEBeneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology)
     FOR IRRITABLE BOWEL SYNDROMECannabinoids and the gut: New developments and emerging concepts
     FOR IRRITABLE BOWEL SYNDROMEEndocannabinoids and the gastrointestinal tract
     FOR IRRITABLE BOWEL SYNDROMECannabinoids and gastrointestinal motility: Animal and human studies

    FOR KIDNEY DISEASE

     FOR KIDNEY DISEASECannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death
     FOR KIDNEY DISEASEChronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
     FOR KIDNEY DISEASEIs There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?
     FOR KIDNEY DISEASEThe emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases

    FOR LIVER DISEASE

     FOR LIVER DISEASEThe endocannabinoid system and liver diseases
     FOR LIVER DISEASECannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
     FOR LIVER DISEASECannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis
     FOR LIVER DISEASETherapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
     FOR LIVER DISEASERole of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol
     FOR LIVER DISEASECannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
     FOR LIVER DISEASECannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation

    FOR METABOLIC SYNDROME

     FOR METABOLIC SYNDROMEThe impact of marijuana use on glucose, insulin, and insulin resistance among US adults
     FOR METABOLIC SYNDROMEThe potential use of cannabidiol in the therapy of metabolic syndrome
     FOR METABOLIC SYNDROMECannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
     FOR METABOLIC SYNDROMEMetabolic syndrome in people with a psychotic illness: is cannabis protective?
     FOR METABOLIC SYNDROMECannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome

    FOR MIGRAINES

     FOR MIGRAINESClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
     FOR MIGRAINESEffects of anandamide in migraine: data from an animal model
     FOR MIGRAINESCannabinoids and hallucinogens for headache
     FOR MIGRAINESThe endocannabinoid system and migraine
     FOR MIGRAINESVariations in the cannabinoid receptor 1 gene predispose to migraine

    FOR MOOD DISORDERS

     FOR MOOD DISORDERSMultiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
     FOR MOOD DISORDERSThe endocannabinoid system and the treatment of mood and anxiety disorders
     FOR MOOD DISORDERSThe endocannabinoid system and psychiatric disorders
     FOR MOOD DISORDERSThe endocannabinoid system in the regulation of emotions throughout lifespan: A discussion on therapeutic perspectives
     FOR MOOD DISORDERSEndocannabinoid system dysfunction in mood and related disorders
     FOR MOOD DISORDERSEffects of cannabidiol (hemp extract) on regional cerebral blood flow

    FOR MOTION SICKNESS

     FOR
    MOTION SICKNESS    		Motion sickness, stress and the endocannabinoid system
     FOR
    MOTION SICKNESS    		Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system
     FOR
    MOTION SICKNESS    		The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis

    FOR MULTIPLE SCLEROSIS

     FOR MULTIPLE SCLEROSISSativex for the management of multiple sclerosis symptoms
     FOR MULTIPLE SCLEROSISTHC and Hemp Extract oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
     FOR MULTIPLE SCLEROSISClinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
     FOR MULTIPLE SCLEROSISCannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
     FOR MULTIPLE SCLEROSISOromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial
     FOR MULTIPLE SCLEROSISNabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
     FOR MULTIPLE SCLEROSISSativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis
     FOR MULTIPLE SCLEROSISA double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
     FOR MULTIPLE SCLEROSISMeta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain(
     FOR MULTIPLE SCLEROSISSativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

    FOR NAUSEA

     FOR NAUSEACannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus
     FOR NAUSEACannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
     FOR NAUSEAInteraction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol in rats and shrews
     FOR NAUSEARegulation of nausea and vomiting by cannabinoids
     FOR NAUSEACannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats
     FOR NAUSEAPreliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting

    FOR NEURODEGENERATION

     FOR NEURODEGENERATIONCannabidiol: A promising drug for neurodegenerative disorders?
     FOR NEURODEGENERATIONCannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
     FOR NEURODEGENERATIONTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
     FOR NEURODEGENERATIONMemory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
     FOR NEURODEGENERATIONCannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection

    FOR NEUROPATHIC PAIN

     FOR NEUROPATHIC PAINMeta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
     FOR NEUROPATHIC PAINSativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
     FOR NEUROPATHIC PAINCannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine
     FOR NEUROPATHIC PAINSativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
     FOR NEUROPATHIC PAINCannabinoids for neuropathic pain
     FOR NEUROPATHIC PAINNeuropathic orofacial pain: Cannabinoids as a therapeutic avenue
     FOR NEUROPATHIC PAINOromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
     FOR NEUROPATHIC PAINThe non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
     FOR NEUROPATHIC PAINVanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
     FOR NEUROPATHIC PAINCannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
     FOR NEUROPATHIC PAINAntihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved
     FOR NEUROPATHIC PAINNon-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
     FOR NEUROPATHIC PAINCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
     FOR NEUROPATHIC PAINRole of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes
     FOR NEUROPATHIC PAINCannabinoids in the management of difficult to treat pain
     FOR NEUROPATHIC PAINMulticenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:Hemp extract and THC extract in patients with intractable cancer-related pain
     FOR NEUROPATHIC PAINMarijuana extract helps prevent chemo pain
     FOR NEUROPATHIC PAINPot users less likely to take painkillers

    FOR OBESITY

     FOR
    OBESITY    		The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
     FOR
    OBESITY    		Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
     FOR
    OBESITY    		Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?
     FOR
    OBESITY    		The endocannabinoid system in obesity and type 2 diabetes
     FOR
    OBESITY    		Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk
     FOR
    OBESITY    		Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes

    FOR OCD

     FOR OCDPlasma and brain pharmacokinetic profile of cannabidiol, cannabidivarine , Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and Hemp Extract action on obsessive-compulsive behaviour (PubMed)
     FOR OCDPlasma and brain pharmacokinetic profile of cannabidiol , cannabidivarine , Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and hemp extract action on obsessive–compulsive behaviour
     FOR OCDInvolvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice

    FOR PARKINSONS DISEASE

     FOR PARKINSONS DISEASEEffects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
     FOR PARKINSONS DISEASEProspects for cannabinoid therapies in basal ganglia disorders
     FOR PARKINSONS DISEASEEvaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties
     FOR PARKINSONS DISEASECannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease
     FOR PARKINSONS DISEASECannabidiol for the treatment of psychosis in Parkinson’s disease
     FOR PARKINSONS DISEASESymptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease
     FOR PARKINSONS DISEASETherapeutic potential of cannabinoids in CNS disease

    FOR PRION

     FOR
    PRION    		Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity
     FOR
    PRION    		Cannabidiol: A prion therapy for mice?
     FOR
    PRION    		Alteration of the endocannabinoid system in mouse brain during prion disease

    FOR PTSD

     FOR PTSDThe endocannabinoid system provides an avenue for evidence-based treatment development for PTSD
     FOR PTSDReductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
     FOR PTSDEnhancing cannabinoid neurotransmission augments the extinction of conditioned fear
     FOR PTSDCannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
     FOR PTSDStress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis
     FOR PTSDMitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
     FOR PTSDCannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment
     FOR PTSDThe endocannabinoid system and extinction learning
     FOR PTSDA current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers
     FOR PTSDCannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
     FOR PTSDNon-antidepressant long-term treatment in post-traumatic stress disorder
     FOR PTSDThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system
     FOR PTSDModulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors

    FOR RHEUMATISM

     FOR
    RHEUMATISM    		Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
     FOR
    RHEUMATISM    		Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases
     FOR
    RHEUMATISM    		Clinical Implications for Cannabinoid Use in the Rheumatic Diseases
     FOR
    RHEUMATISM    		Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases

    FOR SCHIZOPHRENIA

     FOR
    SCHIZOPHRENIA    		Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
     FOR
    SCHIZOPHRENIA    		Cannabidiol as a potential treatment for psychosis
     FOR
    SCHIZOPHRENIA    		Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
     FOR
    SCHIZOPHRENIA    		Medical use of cannabis. Cannabidiol: A new light for schizophrenia?
     FOR
    SCHIZOPHRENIA    		A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
     FOR
    SCHIZOPHRENIA    		Peripheral endocannabinoid system dysregulation in first-episode psychosis
     FOR
    SCHIZOPHRENIA    		Cannabinoids and schizophrenia: Therapeutic prospects
     FOR
    SCHIZOPHRENIA    		Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies
     FOR
    SCHIZOPHRENIA    		Cannabidiol monotherapy for treatment-resistant schizophrenia
     FOR
    SCHIZOPHRENIA    		Cannabis with high cannabidiol content is associated with fewer psychotic experiences
     FOR
    SCHIZOPHRENIA    		Marijuana compound treats schizophrenia with few side effects: Clinical trial
     FOR
    SCHIZOPHRENIA    		Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?

    FOR SICKLE CELL ANEMIA

     FOR SICKLE CELL ANEMIAPain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids
     FOR SICKLE CELL ANEMIACannabis use in sickle cell disease: A questionnaire study
     FOR SICKLE CELL ANEMIACannabinoid Receptor-Specific Mechanisms To Alleviate Pain In Sickle Cell Anemia Via Inhibition Of Mast Cell Activation And Neurogenic Inflammation

    FOR SKIN CONDITIONS

     FOR SKIN CONDITIONSCannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis
     FOR SKIN CONDITIONSCannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
     FOR SKIN CONDITIONSThe endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities
     FOR SKIN CONDITIONSEpigenetic control of skin differentiation genes by phytocannabinoids
     FOR SKIN CONDITIONSEndocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1
     FOR SKIN CONDITIONSCannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation
     FOR SKIN CONDITIONSAttenuation of allergic contact dermatitis through the endocannabinoid system
     FOR SKIN CONDITIONSTopical cannabinoid agonists. An effective new possibility for treating chronic pruritus

    FOR SLEEP DISORDERS

     FOR SLEEP DISORDERSThe nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent
     FOR SLEEP DISORDERSCannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine
     FOR SLEEP DISORDERSEffects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
     FOR SLEEP DISORDERSEffect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults
     FOR SLEEP DISORDERSCannabidiol, a constituent of Cannabis sativa, modulates sleep in rats
     FOR SLEEP DISORDERSEndocannabinoid modulation of cortical up-states and NREM sleep
     FOR SLEEP DISORDERSIntranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat

    FOR SPINAL CORD INJURY

     FOR SPINAL CORD INJURYCannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury
     FOR SPINAL CORD INJURYCannabis effect on spasticity in spinal cord injury
     FOR SPINAL CORD INJURYAn Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease
     FOR SPINAL CORD INJURYModulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury

    FOR STRESS

     FOR STRESSEndogenous cannabinoid signaling is essential for stress adaptation
     FOR STRESSRegulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
     FOR STRESSFunctional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output
     FOR STRESSNeuromodulators, stress and plasticity: a role for endocannabinoid signalling
     FOR STRESSDownregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress
     FOR STRESSEndocannabinoids and stress
     FOR STRESSStress regulates endocannabinoid-CB1 receptor signaling
     FOR STRESSChronic Stress Impairs α1-Adrenoceptor-Induced Endocannabinoid-Dependent Synaptic Plasticity in the Dorsal Raphe Nucleus
     FOR STRESSEndocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance
     FOR STRESSCannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression
     FOR STRESSCannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory
     FOR STRESSThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
     FOR STRESSLow-frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid

    FOR STROKE/TBI

     FOR STROKE/TBICannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
     FOR STROKE/TBICannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism
     FOR STROKE/TBICannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism (
     FOR STROKE/TBICannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
     FOR STROKE/TBIProtective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice
     FOR STROKE/TBIRepeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance